Unique ID issued by UMIN | UMIN000007591 |
---|---|
Receipt number | R000008925 |
Scientific Title | Randomized Controlled Trial to evaluate the efficiency of absorbable barbed suture (V-Loc180) during Laparoscopic Myomectomy |
Date of disclosure of the study information | 2012/03/29 |
Last modified on | 2016/09/30 16:08:20 |
Randomized Controlled Trial to evaluate the efficiency of absorbable barbed suture (V-Loc180) during Laparoscopic Myomectomy
Randomized Controlled Trial to evaluate the efficiency of absorbable barbed suture (V-Loc180) during Laparoscopic Myomectomy
Randomized Controlled Trial to evaluate the efficiency of absorbable barbed suture (V-Loc180) during Laparoscopic Myomectomy
Randomized Controlled Trial to evaluate the efficiency of absorbable barbed suture (V-Loc180) during Laparoscopic Myomectomy
Japan |
Uterine myoma
Obstetrics and Gynecology |
Others
NO
The objective of this study was to confirm the superiority of a test treatment group using V-Loc180 to a current standard of care group using a multifilament suture Polysorb in patients undergoing Laparoscopic Myomectomy, using a randomized comparative study of the suturing time in the uterine wall defect etc.
Safety,Efficacy
Suturing time in the uterine wall defect
Blood loss
Amount of drainage
Duration of drain placement
Length of hospital stay
Adverse events(intraoperative and postoperative)
Degree of adhesion formation by second-look
Number of sutures used
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Active
2
Treatment
Device,equipment |
Group A:V-Loc180
Group B:Polysorb
Not applicable |
Not applicable |
Female
1) Interstitial myoma of the uterus
2) Myomas can be closed with single layer suture
3) Within 3 uterine fibroids
4) Within a 10cm. uterine fibroid in diameter
5) No history of gynecological surgery(myomectomy, systectomy)
6) Healthy organ function
7) Obtained the written informed consent
1) Active bacterial infection or fungal infection
2) Under continuing systemic administration (intravenous or oral) of steroids
3) Complicated condition with uncontrolled diabetes mellitus(HbA1c >8.0%).
4) Judged difficulty due to study complications related to a psychiatric disorder or psychological symptoms
5) Judged unsuitable patient for study participation by the investigator for any other reason
60
1st name | |
Middle name | |
Last name | Iwaho Kikuchi M.D. |
Juntendo UniversityHospital
Department of Obstetrics and Gynecology
Hongo 3-1-3, Bunkyo-ku, Tokyo 113-8431, Japan
1st name | |
Middle name | |
Last name | Iwaho Kikuchi M.D. |
Juntendo UniversityHospital
Department of Obstetrics and Gynecology
Hongo 3-1-3, Bunkyo-ku, Tokyo 113-8431, Japan
Juntendo UniversityHospital
Department of Obstetrics and Gynecology
Covidien Japan Inc.
Profit organization
NO
2012 | Year | 03 | Month | 29 | Day |
Unpublished
Completed
2012 | Year | 02 | Month | 05 | Day |
2012 | Year | 05 | Month | 01 | Day |
2012 | Year | 03 | Month | 28 | Day |
2016 | Year | 09 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008925